Approvals/CIMA-AEMPS/NEVIRAPINA AUROVITAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

NEVIRAPINA AUROVITAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d10bd499ca2bc3b1
Drug Cima Aemps Name: NEVIRAPINA AUROVITAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 85896
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2021-04-08
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 400 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Aurovitas Spain, S.A.U.

NEVIRAPINA

400 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 8, 2021

Approval ID

d10bd499ca2bc3b1

Type

Standard